Andere talen Insulet Corporation

Aandelen

PODD

US45784P1012

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
166,2 ^USD	+0,92%		-5,12%	-23,38%

20/03	Amerikaanse aandelenmarkten sluiten woensdag hoger nadat de Fed de rente stabiel houdt	MT
20/03	Insulet benoemt Ana Maria Chadwick tot financieel directeur	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024	03/04
US Equity Markets Close Higher Wednesday as Fed Holds Rates Steady	20/03
Insulet Names Ana Maria Chadwick Finance Chief	20/03
Insulet Appoints Ana Maria Chadwick as Chief Financial Officer	20/03
Insulet Corporation Appoints Ana Maria Chadwick as Executive Vice President, and Treasurer, Effective April 22, 2024	20/03
Insulet Corporation Announces Chief Financial Officer Changes	20/03
3M Board Approves Healthcare Unit Spinoff -- Update	08/03
Insulet Says Trial Shows Omnipod 5 Insulin Delivery System Superior to Pump Therapy	08/03
Insulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy	08/03
Insulet Corporation Presents Positive Results from its First Randomized Controlled Trial Showing Improved Glycemic and Patient-Reported Outcomes in Type 1 Diabetes with the Omnipod 5 Automated Insulin Delivery System (Omnipod 5)	08/03
Insulet to Present Results from First Omnipod 5 Randomized Controlled Trial at the 17th International Conference on Advanced Technologies and Treatments for Diabetes	06/03
Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)	05/03
Insulet Corporation to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17Th International Conference on Advanced Technologies & Treatments for Diabetes	05/03
Stocks in motion: Alphabet drops as Microsoft signs another AI partnership	26/02
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024	23/02
Insulet forecasts weak annual revenue growth; shares drop	22/02
Insulet Q4 Adjusted Earnings, Revenue Increase; Q1, 2024 Revenue Outlook Set	22/02
Insulet: Q4 Earnings Snapshot	22/02
Insulet Reports Full Year 2023 Revenue Increase of 30% (30% Constant Currency1) and Fourth Quarter 2023 Revenue Increase of 38% Year-Over-Year (37% Constant Currency)	22/02
Earnings Flash (PODD) INSULET CORPORATION Posts Q4 EPS $1.40, vs. Street Est of $0.66	22/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Insulet Corporation

Aandelen

PODD

US45784P1012

Andere talen

Filters